Merck ends study of cholesterol drug

Merck in $1bn US Vioxx settlement
US drugs firm Merck & Co agrees to pay almost $1bn to settle charges arising from the marketing of one of its drugs, Vioxx, the US Department of Justice says.

FDA backs Vytorin for kidney disease patients
Share: FDA backs Vytorin for kidney disease patients WASHINGTON (AP) — The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and...

Newspaper: FDA found concerns at Merck vaccine plant
TRENTON, N.J. (AP) -- Contaminated children's vaccines and other potentially serious concerns were spotted by federal regulators who combed Merck & Co.'s vaccine plant in the Philadelphia...

The Unwritten Rules of Friendship: Simple Strategies...
"Nobody likes me!" is a complaint that parents hear all too often, and few utterances make them feel more helpless. Now help is at hand: This practical and compassionate guidebook enables...

Burt's Bees Free Head to Toe Starter Kit